Docket
38033
Teva Canada Limited v. Janssen Inc., Janssen-Ortho LLC, Janssen Pharmaceuticals, Inc., OMJ Pharmaceuticals, Inc. and Daiichi Sankyo Company, Limited
(Federal) (Civil) (By Leave)
(Sealing order)
Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.
| Date | Proceeding | Filed By (if applicable) |
|---|---|---|
| 2018-11-16 | Close file on Leave | |
| 2018-11-09 | Copy of formal judgment sent to Registrar of the Court of Appeal and all parties | |
| 2018-11-09 | Judgment on leave sent to the parties | |
| 2018-11-08 | Judgment of the Court on the application for leave to appeal, The motion to add Jansseen-Ortho LLC, Janssen Pharmaceuticals, Inc. and OMJ Pharmaceuticals, Inc. as parties to the application for leave to appeal is granted. The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-244-16, 2018 FCA 33, dated January 24, 2018, is dismissed with costs. Dismissed, with costs |
|
| 2018-11-08 | Decision on motion to add or substitute parties, Please see judgment on application for leave to appeal. Granted |
|
| 2018-09-17 | All materials on application for leave submitted to the Judges, for consideration by the Court | |
| 2018-09-17 | Submission of motion to add or substitute parties, for consideration by the Court | |
| 2018-04-26 | Certificate (on limitations to public access), (Letter Form), Form 23B | Janssen Inc., Janssen-Ortho LLC, Janssen Pharmaceuticals, Inc., OMJ Pharmaceuticals, Inc. and Daiichi Sankyo Company, Limited |
| 2018-04-26 | Certificate (on limitations to public access), (Letter Form), Form 23A | Janssen Inc., Janssen-Ortho LLC, Janssen Pharmaceuticals, Inc., OMJ Pharmaceuticals, Inc. and Daiichi Sankyo Company, Limited |
| 2018-04-26 | Notice of name, (Letter Form) | Janssen Inc., Janssen-Ortho LLC, Janssen Pharmaceuticals, Inc., OMJ Pharmaceuticals, Inc. and Daiichi Sankyo Company, Limited |
| 2018-04-26 | Respondent's response on the application for leave to appeal, (Book Form), Sealed: 2 redacted copies files. , Completed on: 2018-04-26 | Janssen Inc., Janssen-Ortho LLC, Janssen Pharmaceuticals, Inc., OMJ Pharmaceuticals, Inc. and Daiichi Sankyo Company, Limited |
| 2018-04-03 | Certificate (on limitations to public access), Form 23B | Teva Canada Limited |
| 2018-04-03 | Certificate (on limitations to public access), Form 23A | Teva Canada Limited |
| 2018-03-29 | Letter acknowledging receipt of an incomplete application for leave to appeal, (FILE OPENED 2018-03-29) | |
| 2018-03-29 | Notice of name | Teva Canada Limited |
| 2018-03-26 | Motion to add or substitute parties, (Book Form), Completed on: 2018-04-03 | Teva Canada Limited |
| 2018-03-26 | Application for leave to appeal, (Book Form), (2 volumes), Form 23A amended, form 23B and electronic version of the motion missing (Received 2018-04-03), Completed on: 2018-04-18 | Teva Canada Limited |
- Date modified: